Please login to the form below

Not currently logged in

Redx names former Bayer exec as chairman

Frank Armstrong brings decades of experience to infectious disease biotech

Frank Armstrong, RedxRedx Pharma has appointed Dr Frank Armstrong as non-executive chairman.

Dr Armstrong has decades of experience in the pharma industry, including spells as executive VP and head of worldwide product development at Bayer and head of medical science and innovation at Merck Serono.

More recently he has worked as an independent consultant for pharma and biotech companies as well as serving on several company boards and these include current chairman positions at CardioRentis, Summit PLC and Xceleron.

He will now help guide Redx as it advances its research efforts into infectious diseases and cancer.

Dr Peter Jackson, co-founder and director at Redx, said: “[Frank's] pharma business experience and clinical insight will make a valuable contribution to our plans for further growth and he is extremely well networked internationally.”

To date this growth includes the creation of a research centre at AstraZeneca's (AZ) former site in Alderley Park, Cheshire in the UK.

Redx is also working with AZ and this week announced the two companies had signed a collaboration to research the genetic drivers of tumour growth.

4th September 2014

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

Our higher purpose is to deliver better communication to increase and speed up the ability of patients to access better...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...